Episode 20 - Amit Kumar, Chairman, President and CEO at Anixa Biosciences

Thank you for tuning into another episode of Bio Hub! Today, we have the privilege of hosting Amit Kumar, a seasoned leader in the biotech industry and the current CEO & Chairman of Anixa Biosciences. Amit's experience is vast, spanning over two decades in leadership roles across the biotech landscape. He has previously served as CEO of CombiMatrix, a key player in molecular diagnostics, as well as GFF, and is also the Executive Chairman and co-founder of Actym Therapeutics, a company advancing immune oncology treatments. Now, at the helm of Anixa Biosciences, Amit is focused on addressing some of the most critical unmet needs in oncology. Under his leadership, the company is advancing cutting-edge therapies and vaccines aimed at tackling cancer, including innovative approaches in immunotherapy and vaccine development. Amit’s deep expertise, from startups to larger biotech companies, gives him a unique perspective on how to steer innovative science towards tangible clinical outcomes. We're excited to dive into his journey, the challenges and successes along the way, and what's next for Anixa and the broader biotech space.